|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7900 EUR | +0.64% |
|
+0.13% | +13.83% |
| 07-22 | Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications | CI |
| 06-29 | Valbiotis Raises EUR10 Million for Commercial Development, Working Capital | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 0.891 | 1.212 | 1.154 |
| Spread/Res. | -11.34% | -34.82% | -31.54% |
| Spread/Supp. | +6.04% | +11.27% | +43.64% |
| Support | 0.745 | 0.71 | 0.55 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALVAL Stock
- Charts Valbiotis
Select your edition
All financial news and data tailored to specific country editions
